1. Home
  2. CLMT vs AGIO Comparison

CLMT vs AGIO Comparison

Compare CLMT & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calumet Specialty Products Partners L.P.

CLMT

Calumet Specialty Products Partners L.P.

HOLD

Current Price

$32.69

Market Cap

2.1B

Sector

Energy

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$31.84

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMT
AGIO
Founded
1916
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
CLMT
AGIO
Price
$32.69
$31.84
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$28.65
$38.88
AVG Volume (30 Days)
756.6K
894.5K
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
85.39
N/A
EPS
N/A
N/A
Revenue
$4,137,100,000.00
$43,011,000.00
Revenue This Year
$3.94
$76.75
Revenue Next Year
$1.07
$170.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.94
$22.24
52 Week High
$38.75
$46.00

Technical Indicators

Market Signals
Indicator
CLMT
AGIO
Relative Strength Index (RSI) 41.87 65.16
Support Level $30.29 $26.71
Resistance Level $33.27 $36.07
Average True Range (ATR) 1.39 1.57
MACD -0.37 0.44
Stochastic Oscillator 10.74 98.56

Price Performance

Historical Comparison
CLMT
AGIO

About CLMT Calumet Specialty Products Partners L.P.

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: